Please assess the completion status of the following clinical trial:

Trial Title: Hospital Management of Hyperglycemia Study of Insulin Glargine Plus Insulin Lispro Versus Human Regular Insulin

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Major Inclusion Criteria:~* No known history of diabetes~* Admission or pre-entry plasma glucose (PG) level between 140 and 400 mg/dL~* Non-critically ill and admitted to acute care medical services~* Have a body mass index greater than or equal to 18.5 kg/m\^2 and less than or equal to 45 kilograms per square meter (kg/m\^2)~Major Exclusion Criteria:~* Received any insulin/analog therapy for longer than 108 hours prior to study entry or intermediate- or long-acting insulin/analogs (neutral protamine Hagedorn, detemir, or glargine) in the 24 hours prior to randomization or any intravenous insulin therapy prior to randomization~* Laboratory evidence of diabetic ketoacidosis for patients with pre-randomization PG greater than 250 mg/dL~* Have taken any oral or injectable antihyperglycemic medications other than insulin within 3 months prior to study entry~* Have acute critical illness or are expected to require admission to an ICU or equivalent or be treated with glucocorticoid therapy during the hospital study period~* Expected hospitalization less than 24 hours post-randomization

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Sliding scale regular insulin (Type: ACTIVE_COMPARATOR): None
- Basal-bolus therapy (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).